As for the laboratory findings and scores, both the ALT and AST levels were significantly higher in the IBD-MASLD group compared to the IBD-NAFLD and IBD groups (27 ± 26 vs. 24 ± 9 vs. 19 ± 11 UI/L, p = 0.001 and 23 ± 12 vs. 25 ± 9 vs. 20 ± 13 UI/L, p = 0.017; respectively). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.